4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-19-060101
EVP and CCO sold 14,521 shares at an average $50.46 ($732,792)
- EVP and CCO acquired 14,521 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YANG MICHAEL J. EVP and CCO | 2019-12-09 | Option exercise | +14,521 | $35.86 | $520,723 | 16,144 | D |
| YANG MICHAEL J. EVP and CCO | 2019-12-09 | Sale | −11,019 | $50.60 | $557,506 | 5,125 | D |
| YANG MICHAEL J. EVP and CCO | 2019-12-09 | Sale | −3,502 | $50.05 | $175,286 | 1,623 | D |
| Derivatives | |||||||
| YANG MICHAEL J. EVP and CCO | 2019-12-09 | Option exercise · Stock Option (Right to Buy) | −14,521 | 385,479 | D | ||
| Open-market sales · 14,521 sh · avg $50.46 · $732,792 | |||||||
Loading xslF345X03/doc4.xml…